These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19347985)

  • 1. Extracapsular lymph node involvement is a negative prognostic factor after neoadjuvant chemoradiotherapy in locally advanced esophageal cancer.
    D'Journo XB; Avaro JP; Michelet P; Trousse D; Tasei AM; Dahan L; Doddoli C; Guidicelli R; Fuentes P; Seitz JF; Thomas P
    J Thorac Oncol; 2009 Apr; 4(4):534-9. PubMed ID: 19347985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of the extracapsular lymph node involvement on disease-free survival according to the 7th edition of American Joint Committee on Cancer Staging System.
    D'Annoville T; D'Journo XB; Loundou A; Trousse D; Dahan L; Doddoli C; Seitz JF; Thomas PA
    Eur J Cardiothorac Surg; 2013 Sep; 44(3):e207-11; discussion e211. PubMed ID: 23818566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of extracapsular lymph node involvement after neoadjuvant therapy and oesophagectomy.
    Lagarde SM; Navidi M; Gisbertz SS; van Laarhoven HW; Sumpter K; Meijer SL; Disep B; Immanuel A; Griffin SM; van Berge Henegouwen MI
    Br J Surg; 2016 Nov; 103(12):1658-1664. PubMed ID: 27696382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Extracapsular Lymph Node Involvement After Neoadjuvant Chemoradiation Therapy Followed by Surgery in Carcinoma of the Esophagus: A Multicenter Study.
    Depypere LP; Moons J; Mariette C; D'Journo XB; Thomas PA; Hölscher AH; Bollschweiler E; van Berge-Henegouwen MI; Van Lanschot JJB; Lerut TEMR; Nafteux PR
    Ann Surg; 2018 Dec; 268(6):1000-1007. PubMed ID: 28742714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemoradiotherapy for esophageal cancer: impact on extracapsular lymph node involvement.
    Metzger R; Bollschweiler E; Drebber U; Mönig SP; Schröder W; Alakus H; Kocher M; Baldus SE; Hölscher AH
    World J Gastroenterol; 2010 Apr; 16(16):1986-92. PubMed ID: 20419835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracapsular lymph node involvement differs between squamous cell and adenocarcinoma of the esophagus.
    Metzger R; Drebber U; Baldus SE; Mönig SP; Hölscher AH; Bollschweiler E
    Ann Surg Oncol; 2009 Feb; 16(2):447-53. PubMed ID: 19037700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracapsular lymph node involvement is a robust survival predictor in esophageal cancer patients: A pooled analysis.
    Chen D; Mao Y; Zheng Y; Wen J; Song P; Xue Y; Wang W; Sang Y; Chen Y; Dai C
    Eur J Surg Oncol; 2021 Aug; 47(8):1875-1882. PubMed ID: 33795171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracapsular lymph node involvement is a negative prognostic factor in T3 adenocarcinoma of the distal esophagus and gastroesophageal junction.
    Lerut T; Coosemans W; Decker G; De Leyn P; Ectors N; Fieuws S; Moons J; Nafteux P; Van Raemdonck D;
    J Thorac Cardiovasc Surg; 2003 Oct; 126(4):1121-8. PubMed ID: 14566257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can extracapsular lymph node involvement be a tool to fine-tune pN1 for adenocarcinoma of the oesophagus and gastro-oesophageal junction in the Union Internationale contre le Cancer (UICC) TNM 7th edition?†.
    Nafteux P; Lerut T; De Hertogh G; Moons J; Coosemans W; Decker G; Van Veer H; De Leyn P
    Eur J Cardiothorac Surg; 2014 Jun; 45(6):1001-10. PubMed ID: 24477743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracapsular lymph node involvement in node-positive patients with adenocarcinoma of the distal esophagus or gastroesophageal junction.
    Lagarde SM; ten Kate FJ; de Boer DJ; Busch OR; Obertop H; van Lanschot JJ
    Am J Surg Pathol; 2006 Feb; 30(2):171-6. PubMed ID: 16434890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic significance of extracapsular lymph node involvement in node positive patients with colonic cancer.
    Wind J; ten Kate FJ; Kiewiet JJ; Lagarde SM; Slors JF; van Lanschot JJ; Bemelman WA
    Eur J Surg Oncol; 2008 Apr; 34(4):390-6. PubMed ID: 17614246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International Multicenter Study on the Impact of Extracapsular Lymph Node Involvement in Primary Surgery Adenocarcinoma of the Esophagus on Overall Survival and Staging Systems.
    Nafteux PR; Lerut AM; Moons J; Hölscher AH; Bollschweiler E; van Berge Henegouwen MI; Lagarde SM; van Lanschot JJ; Messager M; Mariette C; D'Journo XB; Thomas PA; De Leyn PR
    Ann Surg; 2015 Nov; 262(5):809-15; discussion 815-6. PubMed ID: 26583670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph node harvest in esophageal cancer after neoadjuvant chemoradiotherapy.
    Shridhar R; Hoffe SE; Almhanna K; Weber JM; Chuong MD; Karl RC; Meredith K
    Ann Surg Oncol; 2013 Sep; 20(9):3038-43. PubMed ID: 23625142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of the circumferential resection margin and its definitions in esophageal cancer patients after neoadjuvant chemoradiotherapy.
    Depypere L; Moons J; Lerut T; De Hertogh G; Peters C; Sagaert X; Coosemans W; Van Veer H; Nafteux P
    Dis Esophagus; 2018 Feb; 31(2):. PubMed ID: 29036407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Relevance of Lymph Node Regression After Neoadjuvant Chemoradiation for Esophageal Cancer.
    Philippron A; Bollschweiler E; Kunikata A; Plum P; Schmidt C; Favi F; Drebber U; Hölscher AH
    Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):549-558. PubMed ID: 28043475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Clinically Staged Node-Negative Esophageal Adenocarcinoma and Overall Survival Benefit From Neoadjuvant Chemoradiation.
    Gabriel E; Attwood K; Du W; Tuttle R; Alnaji RM; Nurkin S; Malhotra U; Hochwald SN; Kukar M
    JAMA Surg; 2016 Mar; 151(3):234-45. PubMed ID: 26559488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of extracapsular lymph node involvement on the prognosis of patients with esophageal squamous cell carcinoma.
    Wang M; Yue M; Zhao X; He X; Zhang H; Jin J; Wang H
    Technol Health Care; 2023; 31(5):1771-1786. PubMed ID: 37125578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic histological factors in patients with esophageal squamous cell carcinoma after preoperative chemoradiation followed by surgery.
    Tu CC; Hsu PK; Chien LI; Liu WC; Huang CS; Hsieh CC; Hsu HS; Wu YC
    BMC Cancer; 2017 Jan; 17(1):62. PubMed ID: 28103913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
    Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic relevance of extracapsular lymph node involvement in pancreatic ductal adenocarcinoma.
    Sergeant G; Ectors N; Fieuws S; Aerts R; Topal B
    Ann Surg Oncol; 2009 Nov; 16(11):3070-9. PubMed ID: 19649555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.